essential drug list - State Health Resource Centre, Chhattisgarh

ESSENTIAL DRUG LIST (GRADED)OF CHATTISGARH STATE1. ANAESTHETICS1.1 General anaesthetics and oxygenEther, anaesthetic S Inhalation, volatile liquidHalothane S Inhalation, volatile liquidKetamine S Injection, 50 mg (as hydrochloride)/ml in 10-ml vialNitrous oxide S Inhalation gasOxygen P Inhalation (medicinal gas)Thiopentone sodium S Injection, powder for solution, 0.5 g, 1.0 g (sodium salt) in ampoules1.2 Local anaestheticsBupivacaine P Injection, 0.25%, 0.5% (hydrochloride) in 10ml vialInjection for spinal anaesthesia, 0.5% (hydrochloride) in 4-ml ampouleto be mixed with 7.5% glucose solutionLidocaine P Injection, 1%, 2% (hydrochloride) in 30ml vialinjection for spinal anaesthesia, 5% (hydrochloride) in 2-ml ampouleto be mixed with 7.5% glucose solutionTopical forms, 2-4% (hydrochloride)Lidocaine + Epinephrine(Adrenaline)SInjection 1% Lidocaine (hydrochloride)+ Epinephrine 1:200 000 invial;Dental cartridge 2% Lidocaine (hydrochloride) + Epinephrine 1:80000 in 2.2ml cartridge1.3 Preoperative medication and sedation for short-term proceduresAtropine P Injection, 0.6 micrograms/ml (sulfate) in 1-ml ampoule,Tablet 1mg,Chloral hydrate P Oral solution (elixir) syrup, 200 mg/5mlDiazepam P Injection, 5 mg/ml in 2-ml ampoule;Tablet, 5 mgMorphine S Injection, 10 mg (sulfate or hydrochloride) in 1-ml ampoulePromethazine P Elixir or syrup, 5 mg (hydrochloride)/5ml2. ANALGESICS, ANTIPYRETICS, NON-STEROIDAL ANTI-INFLAMMATORYDRUGS (NSAIDs), DRUGS USED TO TREAT GOUT AND DISEASE MODIFYINGAGENTS IN RHEUMATOID DISORDERS (DMARDs)2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIDs)Acetylsalicylic acid P Tablet, 300 mgIbuprofen P Tablet, 200 mg, 400 mgParacetamol P Tablet 500 mg;

Syrup, 125 mg/5ml2.2 Opioids analgesicsPethidine S Injection 50mg/ml; 1ml ampouleMorphine S Injection, 10 mg in 1-ml ampoule (sulfate or hydrochloride)Naloxone S Injection (hydrochloride) 400 micrograms/ml; 1ml ampoule2.4 Disease modifying agents used in rheumatoid disorders (DMARDs)Chloroquine S Tablet, 150 mg base (as phosphate or sulfate)Methotrexate S Tablet, 2.5 mg (as sodium salt)Sulfasalazine S Tablet, 500 mg3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXISChlorphenamine P Tablet, 4 mg (hydrogen maleate); oral solution, 2mg/5ml;Injection, 10 mg/ml in 1-ml ampouleDexamethasone P Tablet, 500 micrograms, 4 mg;Injection, 4 mg/ml (phosphate -sodium salt) in 1-ml ampouleEpinephrine (adrenaline) P Injection, 1 mg/ml (as hydrochloride or hydrogen tartrate) in 1-mlampouleHydrocortisone P Powder for injection, 100 mg (as sodium succinate) in vialPrednisolone P Tablet, 5 mg4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING4.2 SpecificAtropine P Injection, 1 mg/ml (sulfate) in 1-ml ampouleCalcium Gluconate S Injection, 100 mg/ml in 10-ml ampouleNaloxone S Injection, 400micrograms/ml. (hydrochloride) in 1 ml ampoulePralidoxime P Injection, 500mg/20ml.5. ANTICONVULSANTS/ANTIEPILEPTICSCarbamazepine S Scored tablet, 100 mg, 200 mg; syrup 20mg/mlDiazepam P Injection, 5 mg/ml in 2-ml ampoule (intravenous),Suppository 5mg,Suspension 2mg/5mlMagnesium sulfate P Injection, 500 mg/ml in 2-ml ampoule; 500mg/ml in 10-ml ampoulePhenobarbitone P Tablet, 30mg, 60mg;Syrup 20mg/5mlPhenytoin P Tablet, 25 mg, 100 mg (sodium salt);Injection, 50 mg/ml in 5-ml vial (sodium salt)

Valproic acid S Enteric coated tablet, 100mg, 200 mg, (sodium salt);Liquid for oral use 200mg/5ml.6.ANTI INFECTIVE DRUGS6.1 AnthelminthicsAlbendazole P Chewable tablet, 400 mgDiethyl carbamazine P Tablet, 100 mg (dihydrogen citrate)6.2 Antibacterials6.2.1 Beta Lactam medicinesAmoxicillin P Capsule or tablet, 250 mg, 500 mg (anhydrous);Powder for oral suspension, 125 mg (anhydrous)/5 mlAmpicillin P Powder for injection, 500 mg, (as sodium salt) in vialBenzathine benzyl penicillin P Powder for injection, 1.44 g benzyl penicillin (=2.4 million IU) in 5-mlvialBenzyl penicillin P Powder for injection, 600 mg (= 1 million IU), 3 g (= 5 million IU)(sodium or potassium salt) in vialCloxacillin P Capsule, 500 mg, 1 g (as sodium salt);Powder for oral solution, 125 mg (as sodium salt)/5 ml;Powder for injection, 500 mg (as sodium salt) in vialPhenoxymethylpenicillin P Tablet, 250 mg (as potassium salt);Furazolidone P Tablet 100 mg6.2.2 Other antibacterialsChloramphenicol P Capsule, 250 mg; oral suspension, 150 mg (as palmitate)/5 ml;Powder for injection, 1 g (sodium succinate) in vialCiprofloxacin P Tablet 250 mg (as hydrochloride); for (S),Infusion 2mg/ml in 100ml packs;Doxycycline P Capsule, 100 mg (hydrochloride)Erythromycin S Capsule or tablet, 250 mg, 500 (as stearate) ;Powder for oral suspension, 125 mg/5ml (as stearate);Gentamicin P Injection, 10 mg/ml, 40 mg (as sulfate)/ml in 2-ml vialMetronidazole P Tablet, 200; 400 mg; injection, 500 mg in 100-ml vial;Oral suspension, 200 mg (as benzoate)/5 ml;Nitrofurantoin S Tablet, 100 mgSulfamethoxazole +Trimethoprim6.2.3 Antileprosy medicinesPTablet, 400 mg + 80 mg;Oral suspension, 200 mg + 40 mg/5 ml;

Clofazimine P Capsule, 50 mg, 100 mgDapsone P Tablet, 25 mg, 50 mg, 100 mgRifampicin P Capsule or tablet, 150 mg, 300 mgMinocycline S (R) Tablets 100mg (hydrochloride)- supplied as part of NLEPOfloxacin S(R) Tablets 200,400mg- supplied as part of NLEP6.2.4 Antituberculosis medicinesEthambutol P Tablet, 100 mg-400 mg (hydrochloride)Isoniazid P Tablet, 100mg, -300 mgPyrazinamide P Tablet, 400 mgRifampicin P Capsule or tablet, 150 mg, 300 mg,450 mgStreptomycin P Powder for injection, 1 g (as sulfate) in vial6.3 Antifungal medicinesAmphotericin B S Powder for injection, 50 mg in 1vialFluconazole P Capsule 50 mg; injection 2 mg/ml in vial;Oral suspension 50 mg/5-mlNystatin P Tablet, 500 000 IU; pessary, 100 000 IU6.4 Antiviral medicines6.4.1 Antiherpes medicinesAciclovir S Tablet, 200 mg;Powder for injection 250 mg (as sodium salt) in vial6.4.2.1 Nucleoside reverse transcriptase inhibitors-T6.5 Antiprotozaol Medicines6.5.1 Antiamoebic and antigiardiasis medicinesMetronidazole P Tablet, 200-400 mg; injection, 500 mg in 100-ml vial;Oral suspension 200 mg (as benzoate)/5 ml6.5.2 Antileishmaniasis medicines –Meglumine antimoniate P( R ) Injection, 30%, equivalent to approximately 8.1% antimony, in 5-mlampoule -only in districts where problem identified/reportedPentamidine P( R ) Powder for injection, 200 mg, 300 mg (isetionate) in vial-Only in districts where problem identified/reported6.5.3 Antimalarial medicines6.5.3.1 For curative treatmentArtesunate S Tablet, 50 mg;Artemether S Injection 80 mg amp 1 ml amp; capsule 40mg

Chloroquine P Tablet, 150 mg base (as phosphate or sulfate);Syrup, 50 mg (as phosphate or sulfate)/5 ml;Injection 40 mg (as hydrochloride, phosphate or sulfate)/ml in 5-mlampoulePrimaquine P Tablet, 7.5 mg, 15 mg (as diphosphate)Quinine P Tablet, 300 mg (as bisulfate or sulfate);Injection, 300 mg/ml. (as dihydrochloride) in 2-ml ampouleSulfadoxine- Pyrimethamine P Tablet 500mg+ 25mg,6.6. Insect RepellantDiethyltoluamide P Cutaneous solution: 50%; 75%7. ANTIMIGRAINE MEDICINES7.1 For treatment of acute attackAcetylsalicylic acid P Tablet, 300 mgParacetamol P Tablet, 500 mg7.2 For prophylaxisAtenolol S Tablet, 50 mg (hydrochloride)8. ANTINEOPLASTIC, IMMUNOSUPPRESSIVES AND MEDICINES USED INPALLIATIVE CARE-may be considered for facilities that are designated for cancerchemotherapy.9. ANTIPARKINSONISM MEDICINESTrihexyphenidyl S Tablet, 2 mg (hydrochloride); Injection, 5 mg (lactate) in 1-mlampouleLevodopa + Carbidopa S Tablet, 100 mg + 10 mg; 250 mg + 25 mg10. MEDICINES AFFECTING THE BLOOD10.1 Antianaemia medicinesFerrous salt P Tablet, equivalent to 65 mg elemental iron (sulfate);Oral solution equivalent to 25 mg iron (as sulfate)/mlFerrous salt + folic acid P Tablet equivalent to 60 mg iron + 400 micrograms folic acid(Nutritional supplement for use during pregnancy.)Folic acid P(R) Tablet 1mg, 5mg; Injection, 1 mg (as sodium salt) in 1-ml ampoule forthose areas where SCD is a problemHydroxocobalamin S Injection, 1 mg in 1-ml ampoule10.2 Medicines affecting coagulationHeparin sodium S Injection, 1000 IU/ml, 5000 IU/ml, 20,000 IU/ml in 1-ml or 5mlampoulePhytomenadione S Injection, 10 mg/ml in 5-ml ampoule;

Tablet, 10 mgProtamine sulfate S Injection, 10 mg/ml in 5-ml ampouleWarfarin sodium S Tablet, 1 mg, 2 mg and 5 mg (sodium salt)11. BLOOD PRODUCTS AND PLASMA SUBSTITUTES11.1 Plasma substitutesDextran 70 P( R ) Injectable solution, 6% in glucose intrevenous or 5% in 0.9%sodumchloride intravenous11.2 Plasma fractions for specific use –T12. CARDIOVASCULAR MEDICINES12.1 Antianginal medicinesIsosorbide dinitrate P Tablet (sublingual), 5 mgVerapamil tablets S Tablet, 40 mg, 80 mg (hydrochloride)12.2 Antiarrhythmic medicinesAtenolol S Tablet, 50 mg, 100 mgDigoxin S Tablet, 62.5 micrograms, 250 micrograms;Oral solution 50 micrograms/ml; Injection 250 micrograms/ml in 2-ml ampouleLidocaine S Injection, 20 mg (hydrochloride)/ml in 5-ml ampouleVerapamil S Tablet, 40 mg, 80 mg (hydrochloride);Injection, 2.5 mg (hydrochloride)/ml in 2-ml ampoule12.3 Antihypertensive medicinesAtenolol P Tablet, 50 mg, 100 mgEnalapril P Sored tablet, 25 mgHydrochlorothiazide P scored tablet, 25 mgMethyldopa S Tablet, 250 mgAmlodipine P Tablet 2.5 mg, 5mg,12.4 Medicines used in heart failureEnalapril P (S.I) scored tablet, 2.5 mg,5mg,Digoxin P (S.I.) Tablet, 62.5 micrograms, 250 micrograms;Oral solution, 50 micrograms/ml;Injection, 250 micrograms/ml in 2-ml ampouleDopamine S Injection, 40 mg (hydrochloride) in 5-ml vialHydrochlorothiazide P Tablet, 25 mg, 50 mg12.5 Drugs used in Shock/ Eclampsia

Methydopa S Tablet, 250 mg, 500 mgMagnesium sulfate S Injection, 50 %13. DERMATOLOGICAL MEDICINES (topical)13.1 Antifungal medicinesMiconazole P Ointment or cream, 2% (nitrate)Sodium thiosulfate P Cutaneous solution, 15%13.2 Anti-infective medicinesMethylrosanilinium chloride(gentian violet)P Cutaneous solution, 0.5%;Neomycin sulfate +bacitracinPOintment, 5 mg neomycin sulfate + 500 IU bacitracin zinc/gPotassium permanganate P Cutaneous aqueous solution 1 :10 000Silver sulfadiazine S Cream, 1%, in 500-g containerTincture benzoinP13.3 Anti-inflammatory and antipruritic medicinesBetamethasone P Ointment or cream, 0.1% (as valerate)Hydrocortisone P Ointment or cream, 1% (acetate)13.5 Medicines affecting skin differentiation and proliferationBenzoyl peroxide S Lotion or cream, 5%Salicylic acid S Topical solution 5%Urea S Ointment or cream, 10%Podophyllum resin S Cutaneous solution 10 –2%13.6 Scabicides and pediculicidesGamma BHC P Lotion, 25%14. DIAGNOSTIC AGENTS14.1 Ophthalmic medicinesFluorescein S Eye drops solution, 1% (sodium salt)Tropicamide S Eye drops solution, 0.5%14.2 Radiocontrast mediaAmidotrizoate S Injection, 140-420 mg iodine (as sodium or meglumine salt)/ml in 20-ml ampouleBarium sulfate S Oral aqueous suspension 30 – 200% w/vIohexol S Injection 140 –350 mg iodine/ml in 5-ml, 10-ml and 20-ml ampoule

Iopanoic acid S Tablet, 500 mgPropyliodone S Oily suspension, 500-600 mg/ml in 20-ml ampoule (For administrationonly into the bronchial tree.)15. DISINFECTANTS AND ANTISEPTICS15.1 AntisepticsChlorhexidine P Solution, 5% (digluconate) for dilutionEthanol P Cutaneous solution, 70% (denatured)Polyvidone iodine P Cutaneous solution, 10%15.2 DisinfectantsChlorine base compound P Powder (0.1% available chlorine) for solutionGlutaral S Aqueous solution, 2%16. DIURETICSFurosemide P Tablet, 40 mg ; injection, 10 mg/ml in 2-ml ampouleHydrochlorothiazide P Tablet, 50 mgSpironolactone S Tablet, 25 mg17. GASTROINTESTINAL MEDICINES17.1 Antacids and other anti ulcer medicinesAluminium hydroxide P Tablet, 500 mg; Oral suspension 320mg/5mlRanitidine P Tablet 150 mg; 300mg,Injection ( S )50mg/ 2ml.17.2 Antiemetic medicinesMetoclopramide P Tablet, 10 mg (hydrochloride);Injection, 5 mg (hydrochloride)/ml in 2-ml ampouleDomperidone P Tablet 10mg.Promethazine P Elixir or syrup, 5 mg (hydrochloride)/5 ml;Injection, 25 mg (hydrochloride)/ml in 2-ml ampoule17.3 Antihaemorrhoidal medicinesLocal anaesthetic, astringentand anti-inflammatory drugPOintment or suppository17.4 Anti-inflammatory medicinesHydrocortisone S Suppository 25 mg (acetate); retention enemaSulfasalazine S Tablet, 500 mg; suppository 500 mg;Retention enema17.5 Antispasmodic medicines

Dicyclomine P Tablet 10mg(hydrochloride)17.6 LaxativesBisacodyl P Tablet 5mg,17.7 Medicines used in diarrhoeaOral rehydration salts (forGlucose-electrolyte solution)PPowder, 27.9 g/l; Components to reconstitute 1 litre of glucoseelectrolytesolution:sodium chloride 3.5 g/l;trisodium citrate dihydrate* 2.9 g/l;potassium chloride 1.5 g/l;glucose, 20.0 g/l*Trisodium citrate dihydrate may be replaced by sodium bicarbonate (sodium hydrogen carbonate) 2.5g/l. However, as the stability of thislatter formulation is very poor under tropical conditions, it is only recommended when manufactured for immediate use.18. HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES18.1 Adrenal hormones and synthetic substitutesDexamethasone S Tablet 500 micrograms, 1mg; injection 4 mg/ml (as phosphatedisodium salt) in 1-ml ampouleHydrocortisone S Powder for injection, 100 mg (as sodium succinate) in vialPrednisolone P Tablet 5 mg18.2 Androgens18.3 Contraceptives18.3.1 Hormonal contraceptivesEthinylestradiol +LevonorgestrelEthinylestradiol +NorethisteronePPTablet, 30 micrograms + 150 microgramsTablet, 50 micrograms + 250 micrograms (pack of four)Tablet, 35 micrograms + 1.0 mgLevonorgesterel P Tablet 750mcg, 2- tablet pack18.3.2 Intrauterine devicesCopper-containing deviceP18.3.3 Barrier methodsCondoms with or withoutSpermicide (nonoxinol)Diaphragms with spermicide(nonoxinol)PP18.4 EstrogensEthinylestradiol S Tablet, 10 micrograms, 50 micrograms18.5 Insulins and other antidiabetic agentsGlibenclamide P(S.I.) Tablet, 2.5 mg, 5 mg

Insulin injection (soluble) S Injection, 40 IU/ml in 10-ml vial, 100 IU/ml in 10-ml vialIntermediate-acting insulin S Injection, 40 IU/ml in 10 ml vial; 100 IU/ml in 10 ml vial (ascompound insulin zinc suspension or isophane insulin)Metformin S Tablet, 500 mg (hydrochloride)18.7 ProgestogensNorethisterone S Tablet, 5 mg18.8 Thyroid hormones and antithyroid medicinesLevothyroxine P(S.I.) Tablet, 100 micrograms (sodium salt)Potassium iodide S Tablet, 60 mgPropylthiouracil P(S.I.) Tablet, 50 mg, 100mg19. IMMUNOLOGICALS19.1 Diagnostic agentsAll tuberculins should comply with the WHO Requirements for Tuberculins (Revised 1985). WHO ExpertCommittee on Biological Standardization Thirty-sixth report, (WHO Technical Report Series, No. 745, 1987, Annex1).Tuberculin, purified proteinderivative (PPD)PInjection19.2 Sera and immunoglobulinsAll plasma fractions should comply with the WHO Requirements for the Collection, Processing and Quality Controlof Blood, Blood Components and Plasma Derivatives (Revised 1992). WHO Expert Committee on BiologicalStandardization Forty-third report, (WHO Technical Report Series, No. 840, 1994, Annex 2).Antitetanus immunoglobulin(human)SInjection, 500 IU in vialAnti-D immunoglobulin S Injection, 50, 100, 300 micrograms/ml in vialPolyvalent snake antivenomserumPInjection, 10ml vialDiphtheria antitoxin S Injection, 10 000 IU, 20 000 IU in vialRabies immunoglobulinhuman19.3 VaccinesSInjection, 300 , 1500 IU in vialAll vaccines should comply with the WHO Requirements for Biological Substances.19.3.1 For universal immunizationBCG vaccine P Injection, vialDiphtheria, Pertussis andTetanus combined (DPT)vaccinePInjection, vialHepatitis B vaccine S (R ) Restrict to medical staff (and spouses of HbsAg carriers)

Measles vaccine P Injection,vialDiphtheria, Tetanuscombined ( D T)vaccinePInjection,vialPoliomyelitis vaccine P Oral, dropsTetanus vaccine (tetanustoxoid)PInjection, vial19.3.2 For specific groups of individualsPneumoccal vaccine S ( R) restricted to areas of high sickle cell disease where indicatedRABIES vaccine (inactivated:prepared in cell culture)SInjection,1ml20. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASEINHIBITORSAlcuronium S Injection, 5 mg (chloride)/ml in 2-ml ampouleNeostigmine S Tablet, 15 mg (bromide);Injection, 500 micrograms in 1-ml ampoule; 2.5 mg in 5-ml(metilsulfate) ampouleSuxamethonium S Injection, 50 mg (chloride)/ml in 2-ml ampoule;powder for injection (chloride), in vial21. OPHTHALMOLOGICAL PREPARATIONS21.1 Anti-infective agentsGentamicin P Solution (eye drops), 0.3% (sulfate)Silver nitrate S Solution (eye drops), 1%Tetracycline S Eye ointment, 1% (hydrochloride)Ciprofloxacin S Solution ( eye drops),0.3% w/v sterile aqueous(lactate/hydrochloride)21.2 Anti-inflammatory agentsPrednisolone S Solution, (eye drops), 0.5% (sodium phosphate)21.3 Local anaestheticsTetracaine S Solution (eye drops), 0.5% (hydrochloride)21.4 Miotics and antiglaucoma medicinesAcetazolamide S Tablet, 250 mgPilocarpine S Solution (eye drops), 2%, 4% (hydrochloride or nitrate)Timolol S Solution (eye drops), 0.25%, 0.5% (as maleate)21.5 MydriaticsAtropine S Solution (eye drops), 0.1%; 0.5%, 1% (sulfate)

22.OXYTOCICS AND ANTIOXYTOCICS22.1 OxytocicsErgometrine P Tablet, 125 micrograms (hydrogen maleate);Injection, 200 micrograms (hydrogen maleate) in 1-ml ampouleOxytocin P Injection, 10 IU in 1-ml ampoule22.2 AntioxytocicsIsoxuprine S Tablet 20, 40 mg (hydrochloride),Injection 5mg/ml23. PERITONEAL DIALYSIS SOLUTION— restricted to tertiary care centre where peritoneal dialysis isundertaken24. PSYCHOTHERAPEUTIC MEDICINES24.1 Medicines used in psychotic disordersChlorpromazine P Tablet, 100 mg (hydrochloride);Syrup, 25 mg (hydrochloride)/5ml;Injection, 25 mg (hydrochloride)/ml in 2-ml ampouleFluphenazine S Injection, 25 mg (decanoate or enantate) in 1-ml ampouleHaloperidol S Tablet, 1.5 mg, 5 mg;Injection, 5 mg in 1-ml ampoule,Liquid 2mg/ml24.2 Medicines used in mood disorders24.2.1 Medicines used in depressive disordersImipramine P Tablet, 25 mg (hydrochloride)24.2.2 Medicines used in bipolar disorderscarbamazepine S Tablet, 100 mg, 200 mgLithium carbonate S Tablet, 300 mgValproic acid S Enteric coated tablet, 200 mg, (sodium salt)24.3 Medicines used in generalized anxiety and sleep disordersDiazepam P scored tablet 5 mg25. MEDICINES ACTING ON THE RESPIRATORY TRACT25.1 Antiasthmatic medicinesAminophylline P Injection, 25 mg/ml in 10 ml ampouleEpinephrine (adrenaline) P Injection, 1 mg (as hydrochloride or hydrogen tartrate) in 1-mlampouleSalbutamol P Tablet, 2 mg, 4 mg (as sulfate);

Theophylline P Tablet, 100 mg,25.2 anti tussives and expectorantsSyrup, 2 mg/5 ml;Injection, 50 micrograms (as sulfate)/ml in 5-ml ampoule; Solutionfor use in nebulizers, 5 mg (as sulfate)/ml26. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASEDISTURBANCES26.1 OralOral rehydration salts (forglucose-electrolyte solution)P See section 17.7.1Potassium chloride P Powder for solution 1.5 gm,26.2 ParenteralGlucose P Injectable solution, isotonic 5%, 10%; hypertonic 50%Glucose with sodium chloride S Injectable solution, 4% glucose, 0.18% sodium chloride (equivalent toNa+ 30 mmol/l, Cl- 30 mmol/l)Potassium chloride C Solution, 11.2% in 20-ml ampoule, (equivalent to K+ 1.5 mmol/ml,Cl- 1.5 mmol/ml)Sodium chloride P Injectable solution, 0.9% isotonic (equivalent to Na+ 154 mmol/l, Cl-154 mmol/lSodium hydrogen carbonate P Injectable solution, 1.4% isotonic (equivalent to Na+ 167 mmol/l,HCO 3 - 167 mmol/l); solution, 8.4% in 10-ml ampoule (equivalent toNa + 1000 mmol/l, HCO 3 -1000 mmol/l)Sodium lactate, compoundsolution26.3 MiscellaneousSInjectable solutionWater for injection P 2-ml, 5-ml, 10-ml ampoules27. VITAMINS AND MINERALSAscorbic acid P Tablet, 50 mgIodine P Iodized oil, 1 ml (480 mg iodine) in ampoule (oral or injectable); 0.57ml (308 mg iodine) in dispenser bottle;Capsule, 200 mg.Pyridoxine P Tablet, 25 mg (hydrochloride)Vitamin A syrup P Capsule, 200 000 IU (as palmitate) (110 mg);Oral oily solution 100 000 IU (as palmitate)/ml in multidosedispenser;Thiamine S Injectable, 50 mg (hydrochloride)B complex P Tablet with B1,B2,B6,niacinamide, pantothenate, folic acid,

P = Drugs for the Primary Health Centre; Note that all these drugs are therefore by definition part of the essential drug list ofsecondary and tertiary centres as well.S = Drugs for the community health centre (also known as block PHC), the tehsil level and district level hospitals.P (S.I.) = Specialist Initiated Drugs that may require a specialist consultation or investigation at higher facility to confirmdiagnosis before initiating. But once diagnosed the follow up can be taken on a regular basis with the primary health centre.(R) = in very restricted quantities in special situations.